GVM's logos
Home
 German
Español
Italiano
日本語
Francais
中文
Pусский
الْعَرَبيّة
Scientific stuff Trademarks
Copyrights
FAQ & Contacts
About us
 Gallery Patents
Black drink
Preparation
Bevanda nera
Preparazione
 Tasting
Ingredients - Benefits
 Production Importers Useful Resources Acid reflux

May be a cup of coffee, tea or barley a healthy drink? Read some useful articles and scientific studies.

1) Usually doctors invite people to drink any kind of coffee with moderation, in order to limit the risk of high intake of caffeine which, as a stimulant, it is contraindicated for those who suffer from insomnia, anxious, irritable bowel or hypertension. On th econtrary a study published on "Annals of Internal Medicine" seems to give strong support to the coffee benefits. According to data collected by researchers at the International Agency for Research on Cancer (IARC) and Imperial College of London about half a million European citizens in ten countries, people who drink more coffee a day live longer than average not drinkers. Some studies carried out in the past have highlighted several effects of coffee on health, particularly for the prevention of cardiovascular risk and digestive tract diseases, but without reaching concordant and definitive results. One of the problems is that coffee is prepared in many different ways, from Italian espresso, to a few cups of coffee, to American coffee, consumed much more diluted and at much higher doses. And, depending on the preparation, the concentration of different ingredients changes: caffeine, natural oils (diterpenes) and beneficial antioxidants. The study is the largest on the subject. The authors used the data of a large search called EPIC. This is the European Prospective Investigation into Cancer and Nutrition. The data refer to 521,330 people older than 35 years. The diet followed by the subjects was evaluated with questionnaires and interviews. The highest consumption was found among the Danish population with 900 milliliters per day. The kid in Italy with about 92 milliliters a day. In the 16 years of follow-up, some 42,000 people involved in the study died for several causes. Including circulatory diseases, heart failure and stroke. The differences between consumers and non-consumers of coffee are remarkable. Although the conclusions are to be taken with due caution. Because it's an observational study. Then carried out in conditions not strictly controlled. "We found that higher coffee consumption is associated with a lower death risk for all causes, especially for cardiovascular disease and digestive tract," said Marc Gunter, IARC researcher, co-author of the study. "The most important thing is that these results are similar for all ten European countries, with very different consumer habits; our study provides important information on possible mechanisms of the beneficial effects of coffee. "
It should be noted that such effects have also been found for decaffeinated coffee. Although the two types of consumption can not be clearly separated. Because the same people can usually drink coffee with caffeine. And, occasionally, without caffeine and vice versa. In a subset of 14,000 subjects, the authors also analyzed some biological markers. By noting that coffee drinkers had on average a healthier liver than non-drinkers.
According to the authors, these results are added to the data already obtained in the past. Which indicates that drinking coffee is not only safe but can also have beneficial effects. However, further studies will be required. To clarify which of the different components of the coffee has this protective effect.

Fitness Coffee® is a salutary patented blend since it contains only premium quality roasted coffees and a proprietary formula of sixteen bioavailable medicinal herbs and spices famous in the world for their healthy benefits. So it is indeed fully safe considering that is more salutary than a beverage drunk by billions of people during centuries. Furthermore the real vegetal substances included increase notably the taste of the beverage giving an uncomparable product really enjoyable for a worldwide consumption.

Salutary Coffee: a number of important studies have shown that a right quantity of healthy coffee cups helps people to get more alert boosting the powers of learning and reasoning. Research shows that caffeine may fight depression and even improve physical performance. But the tolerance to coffee may depend on the individual. So that replacing normal heavy coffee with a cup of herbal coffee like the patented Fitness Coffee may be useful for the people searching for a good shape and fitness.

Obviously eating a diet rich of vegetables and fruit and making the holy aerobic half hour every day is fundamental. EGCG in coffee help you to burn more calories.

In studies, researchers found that a combination of caffeine and a 90-mg dose of EGCG taken three times a day can help you burn an extra 80 calories a day. A study conducted by the Canadian government found that soldiers who consumed caffeine in the 12 hours prior to a physical-fitness test not only were able to work out longer before becoming exhausted, but also consumed more oxygen while working out. The body's oxygen requirements are directly related to the speed of the metabolism, so more calories are consumed.

1bis) Fluid-electrolyte and renal indices of hydration during eleven days of controlled caffeine consumption. Armstrong, LE, Pumerantz, AC, Roti, MW, et al. July 2004. In review. Departments of Kinesiology, Nutritional Sciences, Physiology & Neurobiology, University of Connecticut, Storrs, CT. This investigation determined if 3 levels of controlled caffeine consumption affected fluid-electrolyte balance and renal function differently. Fifty-nine active males (mean + SD; age, 21.6 + 3.3 y) consumed 3 mg caffeine·kg-1·d-1 on days 1-6 (equilibration phase). On days 7-11 (treatment phase), subjects consumed either 0 mg (G0; placebo; n=20), 3 mg (G3; n=20), or 6 mg (G6; n=19) caffeine·kg-1·d-1 in capsules; no other dietary caffeine intake was allowed. Subjects maintained detailed records of food and fluid intake. These variables were measured on days 1, 3, 6, 9 and 11: body mass, urine osmolality, urine specific gravity, urine color, 24-hour urine volume, 24-hour Na+ and K+ excretion, 24-hour creatinine, blood urea nitrogen, serum Na+ and K+, serum osmolality, hematocrit, and total plasma protein. No significant differences were detected between groups G0, G3 and G6 (P>0.05) for any of the hydration-relevant variables, including urine volume. Although a few significant differences occurred between days (P<.05), indicating acute within-group perturbations, all hydration indices were within the normal clinical range. In conclusion, no evidence of hypohydration was observed in G3 or G6 during 11 d of controlled caffeine consumption. These findings question the widely accepted notion that caffeine acts chronically as a diuretic.

2) Nutritional strategies to influence adaptations to training. Spriet LL, Gibala MJ. J Sports Sci. 2004 Jan;22(1):127-41. Department of Human Biology and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada. This article highlights new nutritional concerns or practices that may influence the adaptation to training. The discussion is based on the assumption that the adaptation to repeated bouts of training occurs during recovery periods and that if one can train harder, the adaptation will be greater. The goal is to maximize with nutrition the recovery/adaptation that occurs in all rest periods, such that recovery before the next training session is complete. Four issues have been identified where recent scientific information will force sports nutritionists to embrace new issues and reassess old issues and, ultimately, alter the nutritional recommendations they give to athletes. These are: (1) caffeine ingestion; (2) creatine ingestion; (3) the use of intramuscular triacylglycerol (IMTG) as a fuel during exercise and the nutritional effects on IMTG repletion following exercise; and (4) the role nutrition may play in regulating the expression of genes during and after exercise training sessions. Recent findings suggest that low doses of caffeine exert significant ergogenic effects by directly affecting the central nervous system during exercise. Caffeine can cross the blood-brain barrier and antagonize the effects of adenosine, resulting in higher concentrations of stimulatory neurotransmitters. These new data strengthen the case for using low doses of caffeine during training. On the other hand, the data on the role that supplemental creatine ingestion plays in augmenting the increase in skeletal muscle mass and strength during resistance training remain equivocal. Some studies are able to demonstrate increases in muscle fibre size with creatine ingestion and some are not. The final two nutritional topics are new and have not progressed to the point that we can specifically identify strategies to enhance the adaptation to training. However, it is likely that nutritional strategies will be needed to replenish the IMTG that is used during endurance exercise. It is not presently clear whether the IMTG store is chronically reduced when engaging in daily sessions of endurance training or if this impacts negatively on the ability to train. It is also likely that the increased interest in gene and protein expression measurements will lead to nutritional strategies to optimize the adaptations that occur in skeletal muscle during and after exercise training sessions. Research in these areas in the coming years will lead to strategies designed to improve the adaptive response to training.

3) Fluid and fuel intake during exercise. Coyle EF. J Sports Sci. 2004 Jan;22(1):39-55. Human Performance Laboratory, Department of Kinesiology and Health Education, The University of Texas at Austin, Austin, TX. The amounts of water, carbohydrate and salt that athletes are advised to ingest during exercise are based upon their effectiveness in attenuating both fatigue as well as illness due to hyperthermia, dehydration or hyperhydration. When possible, fluid should be ingested at rates that most closely match sweating rate. When that is not possible or practical or sufficiently ergogenic, some athletes might tolerate body water losses amounting to 2% of body weight without significant risk to physical well-being or performance when the environment is cold (e.g. 5-10 degrees C) or temperate (e.g. 21-22 degrees C). However, when exercising in a hot environment ( > 30 degrees C), dehydration by 2% of body weight impairs absolute power production and predisposes individuals to heat injury. Fluid should not be ingested at rates in excess of sweating rate, thus body water and weight should not increase during exercise. Fatigue can be reduced by adding carbohydrate to the fluids consumed so that 30-60 g of rapidly absorbed carbohydrate are ingested throughout each hour of an athletic event. Furthermore, sodium should be included in fluids consumed during exercise lasting longer than 2 h or by individuals during any event that stimulates heavy sodium loss (more than 3-4 g of sodium). Athletes do not benefit by ingesting glycerol, amino acids or alleged precursors of neurotransmitter. Ingestion of other substances during exercise, with the possible exception of caffeine, is discouraged. Athletes will benefit the most by tailoring their individual needs for water, carbohydrate and salt to the specific challenges of their sport, especially considering the environment's impact on sweating and heat stress.

4) Central nervous system effects of caffeine and adenosine on fatigue. Davis JM, Zhao Z, Stock HS, Mehl KA, Buggy J, Hand GA. Am J Physiol Regul Integr Comp Physiol. 2003 Feb;284(2):R399-404.
Department of Exercise Science, Schools of Public Health and Medicine, University of South Carolina, Columbia, SC. Caffeine ingestion can delay fatigue during exercise, but the mechanisms remain elusive. This study was designed to test the hypothesis that blockade of central nervous system (CNS) adenosine receptors may explain the beneficial effect of caffeine on fatigue. Initial experiments were done to confirm an effect of CNS caffeine and/or the adenosine A(1)/A(2) receptor agonist 5'-N-ethylcarboxamidoadenosine (NECA) on spontaneous locomotor activity. Thirty minutes before measurement of spontaneous activity or treadmill running, male rats received caffeine, NECA, caffeine plus NECA, or vehicle during four sessions separated by approximately 1 wk. CNS caffeine and NECA (intracerebroventricular) were associated with increased and decreased spontaneous activity, respectively, but caffeine plus NECA did not block the reduction induced by NECA. CNS caffeine also increased run time to fatigue by 60% and NECA reduced it by 68% vs. vehicle. However, unlike the effects on spontaneous activity, pretreatment with caffeine was effective in blocking the decrease in run time by NECA. No differences were found after peripheral (intraperitoneal) drug administration. Results suggest that caffeine can delay fatigue through CNS mechanisms, at least in part by blocking adenosine receptors.

5) Caffeine, body fluid-electrolyte balance, and exercise performance. Armstrong, LE. Int J Sport Nutr Exerc Metab 2002, 12:189-206. Departments of Kinesiology, Nutritional Sciences, Physiology & Neurobiology, University of Connecticut, Storrs, CT. Recreational enthusiasts and athletes often are advised to abstain from consuming caffeinated beverages (CB). The dual purposes of this review are to (a) critique controlled investigations regarding the effects of caffeine on dehydration and exercise performance, and (b) ascertain whether abstaining from CB is scientifically and physiologically justifiable. The literature indicates that caffeine consumption stimulates a mild diuresis similar to water, but there is no evidence of a fluid-electrolyte imbalance that is detrimental to exercise performance or health. Investigations comparing caffeine (100 – 680 mg) to water or placebo seldom found a statistical difference in urine volume. In the ten studies reviewed, consumption of a CB resulted in 0 - 84 % retention, whereas consumption of water resulted in 0 - 81 % retention, of the initial volume ingested. Further, tolerance to caffeine reduces the likelihood that a detrimental fluid-electrolyte imbalance will occur. The scientific literature suggests that athletes and recreational enthusiasts will not incur detrimental fluid-electrolyte imbalances if they consume CB in moderation and eat a typical U.S. diet. Sedentary members of the general public should be at less risk than athletes because their fluid losses via sweating are smaller.

6) Ergogenic aids in aerobic activity. Juhn MS. Curr Sports Med Rep. 2002 Aug;1(4):233-8. Hall Health Sports Medicine, University of Washington, Seattle, WA. There are many products that are potentially ergogenic for aerobic exercise, although evidence-based support varies. The most popular supplements or ergogenic aids for the endurance athlete are caffeine, antioxidants, erythropoietin, and the dietary practice of carbohydrate loading. Caffeine and carbohydrate loading have the most evidence-based support of being both ergogenic and safe. Erythropoietin is ergogenic but unsafe, and is banned by all major sport-sanctioning bodies, and antioxidants have potential but warrant further study.

7) Caffeine and exercise: metabolism, endurance and performance. Graham TE. Sports Med. 2001;31(11):785-807. Human Biology and Nutritional Sciences, University of Guelph, Ontario, Canada. Caffeine is a common substance in the diets of most athletes and it is now appearing in many new products, including energy drinks, sport gels, alcoholic beverages and diet aids. It can be a powerful ergogenic aid at levels that are considerably lower than the acceptable limit of the International Olympic Committee and could be beneficial in training and in competition. Caffeine does not improve maximal oxygen capacity directly, but could permit the athlete to train at a greater power output and/or to train longer. It has also been shown to increase speed and/or power output in simulated race conditions. These effects have been found in activities that last as little as 60 seconds or as long as 2 hours. There is less information about the effects of caffeine on strength; however, recent work suggests no effect on maximal ability, but enhanced endurance or resistance to fatigue. There is no evidence that caffeine ingestion before exercise leads to dehydration, ion imbalance, or any other adverse effects. The ingestion of caffeine as coffee appears to be ineffective compared to doping with pure caffeine. Related compounds such as theophylline are also potent ergogenic aids. Caffeine may act synergistically with other drugs including ephedrine and anti-inflammatory agents. It appears that male and female athletes have similar caffeine pharmacokinetics, i.e., for a given dose of caffeine, the time course and absolute plasma concentrations of caffeine and its metabolites are the same. In addition, exercise or dehydration does not affect caffeine pharmacokinetics. The limited information available suggests that caffeine non-users and users respond similarly and that withdrawal from caffeine may not be important. The mechanism(s) by which caffeine elicits its ergogenic effects are unknown, but the popular theory that it enhances fat oxidation and spares muscle glycogen has very little support and is an incomplete explanation at best. Caffeine may work, in part, by creating a more favourable intracellular ionic environment in active muscle. This could facilitate force production by each motor unit.

8) Dose-dependent effect of caffeine on reducing leg muscle pain during cycling exercise is unrelated to systolic blood pressure. O'Connor PJ, Motl RW, Broglio SP, Ely MR. Pain. 2004 Jun;109(3):291-8. Department of Exercise Science, University of Georgia, Athens, GA. This double-blind, within-subjects experiment examined the effects of ingesting two doses of caffeine on perceptions of leg muscle pain and blood pressure during moderate intensity cycling exercise. Low caffeine consuming college-aged males ingested one of two doses of caffeine (5 or 10mg.kg(-1) body weight) or placebo and 1h later completed 30 min of moderate intensity cycling exercise (60%). The order of drug administration was counter-balanced. Resting blood pressure and heart rate were recorded immediately before and 1h after drug administration. Perceptions of leg muscle pain as well as work rate, blood pressure, heart rate, and oxygen uptake were recorded during exercise. Caffeine increased resting systolic pressure in a dose-dependent fashion but these blood pressure effects were not maintained during exercise. Caffeine had a significant linear effect on leg muscle pain ratings. The mean (+/-SD) pain intensity scores during exercise after ingesting 10mg.kg(-1) body weight caffeine, 5mg.kg(-1) body weight caffeine, and placebo were 2.1+/-1.4, 2.6+/-1.5, and 3.5+/-1.7, respectively. The results support the conclusion that caffeine ingestion has a dose-response effect on reducing leg muscle pain during exercise and that these effects do not depend on caffeine-induced increases in systolic blood pressure during exercise.

9) Dry mouth: Cappuccino coffee treatment of xerostomia in patients taking tricyclic antidepressants: preliminary report (In Polish) Chodorowski Z. Przegl Lek. 2002;59(4-5):392-3. I Klinika Chorob Wewnetrznych Akademii Medycznej w Gdansku, Poland. Ten patients underwent a trial treatment with cappuccino coffee. All of them (8 university lecturers and 2 clerks) aged from 60 to 69 (average 63) years old, used tricyclic antidepressants because of insomnia as a monosymptomatic type of depression or insomnia as a dominant symptom in the course of depression. One evening dose of doxepin was from 150 to 250 mg (average 225), causing xerostomia the following day, usually between 9-15 o'clock. The five-minute chewing [drinking?] of 15.0 g of cappuccino coffee increased the amount of saliva, decreased xerostomia, and improved the ability of speech. The beneficial effect of coffee lasted from 0.5 to 4 (average about 2) hours. To the best of our knowledge there are no publications dealing with the positive effect of coffee in xerostomia.

10) Coffee reduces diabetes risk among pre-diabetics by over 60%, according to a new study from the University of California at San Diego. The study is the first to expand evidence on diabetes risk reduction to those already glucose intolerant, a precursor to full-blown diabetes. Published in the November issue of Diabetes Care, the study revealed that coffee offered protection at the same, significant levels for those beginning the study with high fasting glucose levels, indicating pre-existing glucose intolerance, as it did for those with normal levels. In fact, those with elevated glucose levels showed a lower risk of developing diabetes than those starting out with normal glucose tolerance. Reduced RiskPast or current coffee drinking resulted in a diabetes risk factor of 0.38 on a scale where 1.0 is average risk in the general population. That means risk was reduced in coffee drinkers by 62%. Uncovering the first evidence that coffee also reduces diabetes risk among pre-diabetics, the risk level came in even lower, at 0.31, for the subgroup with impaired glucose. That means pre-diabetics reduced their risk of developing the disease by almost 70%. These results were independent of age, sex, exercise, body mass index, smoking status, daily alcohol intake, and hypertension. Unlike other studies, they were also independent of the number of cups of coffee consumed daily.

11) N.J. Joins Multi-State Settlement with Coke, Nestle Over Calorie-Burning, Weight Loss Claims for Green Tea Beverage: TRENTON – Attorney General Anne Milgram announced today that New Jersey has entered into a multi-state settlement agreement with Coke, Nestle and Beverage Partners Worldwide (BPW) that resolves questionable claims about Enviga, a green tea beverage marketed by the companies as able to burn extra calories resulting in weight loss. http://www.nj.gov/oag/newsreleases09/022609-ENVIGA-AVC-agreement.pdf

12) From 4 to 6 cups to get healthy benefits from coffee. The Journal of the AmericanMedicalAssociation, concluded that drink daily some cups of coffee can help in the risk of diabetes: coffee contains antioxidants against the cell damage responsible of the type 2 diabetes. Also coffee can help in the cardiovascular risk: some studies show that cardiovascular risk decreases with coffee consumption; Norwegian research studies concluded that drinking one to three cups a day reduced the risk of cardiovascular disease by 24 percent compared with no coffee conumers.

13) President Obama has said a tax on sugary beverages is worth considering, and a study in the New England Journal of Medicine says it could raise $14.9 billion a year and reduce obesity. Editorial writers are debating if a tax would be effective in raising money and in stopping people from drinking soda. http://www.ama-assn.org/amednews/2009/10/12/edsa1012.htm

Part of the above written articles are reported from US National Coffee Association as they invite to use the news posted on their website (disclaimer).
AMERICAN JOURNAL OF CLINICAL NUTRITION, COFFEE IMPAIRS BLOOD GLUCOSE, Vol. 87, No. 5, 1254-1261, May 2008. Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men

Woman’s World magazine, January 29, 2002. Is Coffee Making You Fat?

Johnston KL, Clifford MN, Morgan LM. Coffee acutely modifies gastrointetinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 2003;78:728–33.

Keijzers GB, de Galan BE, Tack CJ, Smits P. Caffeine can decrease insulin sensitivity in humans. Diabetes Care 2002;25:364–9.

Graham TE, Sathasivam P, Rowland M, Marko N, Greer F, Battram D. Caffeine ingestion elevates plasma insulin response in humans during an oral glucose tolerance test. Can J Physiol Pharmacol 2001;79:559–65.

van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005;294:97–104.

Graham TE, Hibbert E, Sathasivam P. Metabolic and exercise endurance effects of coffee and caffeine ingestion. J Appl Physiol 1998;85:883–9.

Harland BF. Caffeine and nutrition. Nutrition 2000;16:522–6.

Nawrot P, Jordan S, Eastwood J, Rotstein J, Hugenholtz A, Feeley M. Effects of caffeine on human health. Food Addit Contam 2003;20:1–30.

Pizziol A, Tikhonoff V, Paleari CD, et al. Effects of caffeine on glucose tolerance: a placebo-controlled study. Eur J Clin Nutr 1998;52:846–9.

Petrie HJ, Chown SE, Belfie LM, et al. Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss. Am J Clin Nutr 2004;80:22–8.

Robinson LE, Savani S, Battram DS, McLaren DH, Sathasivam P, Graham TE. Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes. J Nutr 2004;134:2528–33.

Lane JD, Barkauskas CE, Surwit RS, Feinglos MN. Caffeine impairs glucose metabolism in type 2 diabetes. Diabetes Care 2004;27:2047–8.

Robinson LE, Savani S, Battram DS, McLaren DH, Sathasivam P, Graham TE: Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes. J Nutr 134: 2528–2533, 2004

Lane JD, Hwang AL, Feinglos MN, Surwit RS: Caffeine in coffee exaggerates postprandial hyperglycemia in type 2 diabetes. Endocr Pract 13: 239–243, 2007

Gross TM, Mastrototaro JJ: Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther 2: S19–S26, 2000

Crist GH, Xu B, Lanoue KF, Lang CH: Tissue-specific effects of in vivo adenosine receptor blockade on glucose uptake in Zucker rats. FASEB J 12: 1301–1308, 1998

Han DH, Hansen PA, Nolte LA, Holloszy JO: Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions. Diabetes 47: 1671–1675, 1998

Thong FSL, Graham TE: Caffeine-induced impairment of glucose tolerance is abolished by beta-adrenergic receptor blockade in humans. J Appl Physiol 92: 2347–2352, 2002

Greer F, Hudson R, Ross R, Graham T. Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans. Diabetes 2001;50:2349–54.

Thong FS, Derave W, Kiens B, et al. Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise. Diabetes 2002;51:583–90.

van Dam RM, Feskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2002;360:1477–8.

Salazar-Martinez E, Willett WC, Ascherio A, et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 2004;140:1–8.

Rosengren A, Dotevall A, Wilhelmsen L, Thelle D, Johansson S. Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study. J Intern Med 2004;255:89–95.

Tuomilehto J, Hu G, Bidel S, Lindstrom J, Jousilahti P. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 2004;291:1213–9.

Carlsson S, Hammar N, Grill V, Kaprio J. Coffee consumption and risk of type 2 diabetes in Finnish twins. Int J Epidemiol 2004;33:616–7.

Agardh EE, Carlsson S, Ahlbom A, et al. Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. J Intern Med 2004;255:645–52.

Yamaji T, Mizoue T, Tabata S, et al. Coffee consumption and glucose tolerance status in middle-aged Japanese men. Diabetologia 2004;47:2145–51.

van Dam RM, Willett WC, Manson JE, Hu FB. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care 2006;29:398–403.

Pereira MA, Parker ED, Folsom AR. Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med 2006;166:1311–6.

Battram DS, Arthur R, Weekes A, Graham TE. The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men. J Nutr 2006;136:1276–80.

Lane JD, Hwang AL, Feinglos MN, Surwit RS. Exaggeration of postprandial hyperglycemia in patients with type 2 diabetes by administration of caffeine in coffee. Endocr Pract 2007;13:239–43.
Fredholm BB. Astra Award Lecture: Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol 1995;76:93–101.

Thong FS, Graham TE. Caffeine-induced impairment of glucose tolerance is abolished by beta-adrenergic receptor blockade in humans. J Appl Physiol 2002;92:2347–52.

Avogaro A, Toffolo G, Valerio A, Cobelli C. Epinephrine exerts opposite effects on peripheral glucose disposal and glucose-stimulated insulin secretion: a stable label intravenous glucose tolerance test minimal model study. Diabetes 1996;45:1373–8.

Battram DS, Graham TE, Dela F. Caffeine's impairment of insulin-mediated glucose disposal cannot be solely attributed to adrenaline. J Physiol 200;583:1069-1077.

Spiller MA. The chemical components of coffee. In: Spiller GA, ed. The methylxanthine beverages and foods: chemistry, consumption, and health effects. New York, NY: Alan R. Liss, 1984;91–147.

Gilbert RM. Caffeine consumption. In:Spiller GA, ed. The methylxanthine beverages and foods: chemistry, consumption, and health effects. New York, NY: Alan R. Liss, 1984;185–213.

Farah A, de Paulis T, Moreira DP, Trugo LC, Martin PR. Chlorogenic acids and lactones in regular and water-decaffeinated arabica coffees. J Agric Food Chem 2006;54:374–81.

Shearer J, Farah A, de Paulis T, et al. Quinides of roasted coffee enhance insulin action in conscious rats. J Nutr 2003;133:3529–32.

Shearer J, Sellars E, Farah A, Graham TE, Wasserman DH. Effects of chronic coffee consumption on glucose kinetics in the conscious rat. Can J Physiol Pharmacol 2007;85:823–30.

D'Amicis A, Viani R. The consumption of coffee. In: Garattini S, ed. Caffeine, coffee and health. New York, NY: Raven Press, Ltd, 1993:1–16.

Lundsberg LS. Caffeine consumption. In: Spiller GA, ed. Caffeine. Boca Raton, FL: CRC Press, 1998:199–224.

Salazar-Martinez E, Willett WC, Ascherio A, et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 2004;140:1–8.

Rosengren A, Dotevall A, Wilhelmsen L, Thelle D, Johansson S. Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study. J Intern Med 2004;255:89–95.

van Dam RM, Dekker JM, Nijpels G, Stehouwer CDA, Bouter LM, Heine RJ. Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study. Diabetologia 2004;47:2151–9.

Carlsson S, Hammar N, Grill V, Kaprio J. Coffee consumption and risk of type 2 diabetes in Finnish twins. Int J Epidemiol 2004;33:616–7.

van Dam RM, Hu FB. Coffee Consumption and risk of type 2 diabetes: a systematic review. JAMA 2005;294:97–104.

Greenberg JA, Axen KV, Schnoll R, Boozer CN. Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes Relat Metab Disord 2005;29:1121–9.

Isogawa A, Noda M, Takahashi Y, Kadowaki T, Tsugane S. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2003;361:703–4.

Arnlov J, Vessby B. Coffee consumption and insulin sensitivity. JAMA 2004;291:1199–201.

Agardh EE, Carlsson S, Ahlbom A, et al. Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. J Intern Med 2004;255:645–52.

Soriguer F, Rojo-Martinez G, Esteva de Antonio I. Coffee consumption and type 2 diabetes mellitus. Ann Intern Med 2004;141:321–2 (letter).

Yamaji T, Mizoue T, Tabata S, et al. Coffee consumption and glucose tolerance status in middle-aged Japanese men. Diabetologia 2004;47:2145–51.

Wu T, Willett WC, Hankinson SE, Giovannucci E. Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care 2005;28:1390–6.

Faerch K, Lau C, Tetens I, et al. A statistical approach based on substitution of macronutrients provides additional information to models analyzing single dietary factors in relation to type 2 diabetes in Danish adults: the Inter99 study. J Nutr 2005;135:1177–82.

Bidel S, Hu G, Sundvall J, Kaprio J, Tuomilehto J. Effects of coffee consumption on glucose tolerance, serum glucose and insulin levels—a cross-sectional analysis. Horm Metab Res 2006;38:38–43

Saremi A, Tulloch-Reid M, Knowler WC. Coffee consumption and the incidence of type 2 diabetes. Diabetes Care 2003;26:2211–2.

Reunanen A, Heliovaara M, Aho K. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2003;36:702–3.

Mackenzie T, Brooks B, O'Connor G. Beverage intake, diabetes, and glucose control of adults in America. Ann Epidemiol 2006 Jan 31; Epub ahead of print.

Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 1998;21:475–6.

King H, Aubert R, Herman W. Global burden of diabetes, 1995–2025. Prevalence, numerical estimates and projections. Diabetes Care 1998;21:1414–31.

Spiller MA. The chemical components of coffee. In: Spiller GA, ed. Caffeine. Boca Raton, FL: CRC Press, 1998:97–161.

Lopez-Garcia E, van Dam RM, Rajpathak S, Willett WC, Manson JE, Hu FB. Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr 2006;83:674–80.

Zheng G, Sayam K, Okubo T, Juneja LR, Oguni I. Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice. In Vivo 2004;18:55–62.

Cheung WT, Lee CM, Ng TB. Potentiation of the antioipolytic effect of 2-chloroadenosine after chronic caffeine treatment. Pharmacology 1988;36:331–9.

Muroyama K, Murosaki S, Yamamoto Y, Odaka H, Chung HC, Miyoshi M. Anti-obesity effects of a mixture of thiamin, arginine, caffeine, and citric acid in non-insulin dependent diabetic KK mice. Nutr Sci Vitaminol (Tokyo) 2003;49:56–63.

Choi SB, Park CH, Park S. Effect of cola intake on insulin resistance in moderate fat-fed weaning male rats, J Nutr Biochem 2002;13:727–33.

Han LK, Takaku T, Li J, Kimura Y, Okuda H. Anti-obesity action of oolong tea. Int J Obes Relat Metab Disord 1999;23:98–105.

Bukowiecki LJ, Lupien J, Follea N, Jahjah L. Effects of sucrose, caffeine and cola beverages on obesity, cold resistance, and adipose tissue cellularity. Am J Physiol 1983;244:R500–7.

Astrup A, Breum L, Toubro S, Hein P, Quaade F. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. Int J Obes Relat Metab Disord 1992;16:269–77.

Kovacs EMR, Lejeune MPGM, Nijs I, Westerterp-Plantenga MS. Effects of green tea on weight maintenance after body-weight loss. Br J Nutr 2004;91:431–7.

Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J. Long-term non-pharmacological weight loss interventions for adults with prediabetes. Cochrane Database Syst Rev 2005;(2):CD005270.

Dulloo A, Geissler C, Horton T, Miller D. Normal cafeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. Am J Clin Nutr 1989;49:44–50.

Jung RT, Shetty PS, James WPT, Barrand MA, Callingham BA. Caffeine: its effects on catecholamines and metabolism in lean and obese subjects. Clin Sci 1981;60:527–35.

Astrup A, Toubro S, Cannon S, Hein P, Breum L, Madsen J. Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am J Clin Nutr 1990;51:759–67.

Haldi J, Bachmann G, Ensor C, Wynn W. The effects of various amounts of caffeine on the gaseous exchange and the respiratory quotient in man. J Nutr 1941;21:307–12.

Horst K, Willson RJ, Smith RG. The effect of coffee and decaffeinated coffee on oxygen consumption, pulse rate and blood pressure. J Pharmacol. Exp Therap 1936;58:294–304.

Hollands M, Cawthorne MA. A simple apparatus for comparative measurements of energy expenditure in human subjects: the thermic effect of caffeine. Am J Clin Nutr 1981;34:2291–4.

Acheson KJ, Zahorska-Markiewicz B, Anantharaman K, Jequier E. Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr 1980;33:989–97.

Graham TE. Caffeine and exercise: metabolism, endurance and performance. Sports Med 2001;31:785–807.

Bracco D, Ferrarra JM, Arnaud MJ, Jequier E, Schutz Y. Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Physiol 1995;269:E671–8.

Costill DL, Dalsky GP, Fink WJ. Effects of caffeine ingestion on metabolism and exercise performance. Med Sci Sports 1978;10:155–8.

Ryu S, Choi SK, Joung SS, Suh H, Cha YS, Lee S, Lim K. Caffeine as a lipolytic food component increases endurance performance in rats and athletes. J Nutr Sci Vitaminol (Tokyo) 2001;47:139–46.

Dulloo AG, Duret C, Rohrer D, et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-hr energy expenditure and fat oxidation in humans. Am J Clin Nutr 1999;70:1040–5.
Arciero PJ, Gardner AW, Calles-Escandon J, Benowitz NL, Poehlman ET. Effects of caffeine ingestion on NE kinetics, fat oxidation, and energy expenditure in younger and older men. Am J Physiol 1995;268(6 Pt 1):E1192–8.

Jungas RL, Ball EG. Studies on the metabolism of adipose tissue. XII. The effects of insulin and epinephrine on free fatty acid and glycerol production in the presence and absence of glucose. Biochemistry 1963;2:383–8.

Daubresse J-C, Luyckx A, Demey-Ponsart E, Franchimont R, Lefebvre P. Effects of coffee and caffeine on carbohydrate metabolism, free fatty acid, insulin, growth hormone and cortisol plasma levels in man. Acta Diabetol Lat 1973;10:1069–84.

Keijzers GB, De Galan BE. Caffeine can decrease insulin sensitivity in humans. Diabetes Care 2002;25:364–9.

Thong FS, Graham TE. Caffeine-induced impairment of glucose tolerance is abolished by beta-adrenergic receptor blockade in humans, J Appl Physiol 2002;92:2347–52.

Bellet S, Kershbaum A, Finck EM. Response of free fatty acids to coffee and caffeine. Metabolism 1968;17:702–7.

Avogaro P, Capri C, Pais M, Cazzolato G. Plasma and urine cortisol behaviour and fat mobilization in man after coffee ingestion. Israel J Med Sci 1973;9:114–9.

Sawynok J, Yaksh TL. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev 1993;45:43–85.

Whitsett TL, Manion CV, Christensen HD. Cardiovascular effects of coffee and caffeine. Am J Cardiol 1984;53:918–22.

Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999;51:83–133.

Daly JW, Fredholm BB. Mechanisms of action of caffeine on the nervous system. In: Nehlig A, ed. Coffee, tea, chocolate and the brain. Boca Raton, FL: CRC Press, 2004:1–12.

Daly JW. Mechanism of action of caffeine. In: Garattini S, ed. Caffeine, coffee and health. New York, NY: Raven Press, Ltd, 1993:97–150.

Reppert SM, Weaver DR, Stehle JH, Rivkees SA. Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord. Mol Endocrinol 1991;5:1037–48.

Dixon AK, Gubitz AK, Sirinathsinghji DJ, Richardson PJ, Freeman TC. Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 1996;118:1461–8.

Robertson D, Wade D, Workman R, Woosley RL, Oates JA. Tolerance to the humoral and hemodynamc effect of caffeine in man. J Clin Invest 1981;67:1111–7.

Benowitz NL, Jacob P III, Mayan H, Denaro C. Sympathomimetic effects of paraxanthine and caffeine in humans. Clin Pharmacol Ther 1995;58:684–91.

Fredholm BB. Effects of adenosine, adenosine analogues and drugs inhibiting adenosine inactivation of lipolysis in rat fat cells. Acta Physiol Scand 1978;102:191–8.

Rebuffe-Scrive M, Anderson B, Olbe L, Bjorntorp P. Metabolism of adipose tissue in intraabdominal depots in severly obese men and women. Metabolism 1990;39:1021–5.

Strubelt O. The influence of reserpin, propranolol and adrenal medullectomy on the hyperglycaemic actions of theophylline and caffeine. Arch Int Pharmacodynam 1969;179:215–24.

Levine JA, Lanningham-Foster LM, McCrady SK, et al. Interindividual variation in posture allocation: possible role in human obesity. Science 2005;307:584–6.

Lane JD, Surwit RS, Barkauskas CE, Feinglos MN. Caffeine impairs glucose metabolism in type 2 diabetes. Diabetes Care 2004;27:2047–8.

Greer F, Hudson R, Ross R, Graham T. Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans. Diabetes 2001;50:2349–54.

Petrie HJ, Chown SE, Belfie LM, et al. Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss. Am J Clin Nutr 2004;80:22–8.

Robinson LE, Savani S, Battram DS, McLaren DH, Sathasivam P, Graham TE. Caffeine ingestion before andoral glucose tolerance test impairs blood glucose management in men with type 2 diabetes. J Nutr 2004;134:2528–33.

Pizziol A, Tikhonoff V, Paleari CD, et al. Effects of caffeine on glucose tolerance: a placebo-controlled study. Eur J Clin Nutr 1998;52:846–9.

Battram DS, Arthur R, Weekes A, Graham T. The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men. J Nutr 2006;136:1276–80.

Johnston KL, Clifford MN, Morgan LM. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 2003;78:728–33.

Wachmann A, Hattner RS, George B, Bernstein DS. Effects of decaffeinated and nondecaffeinated coffee ingestion on blood glucose and plasma radioimmuno-reactive insulin responses to rapid intravenous infusion of glucose in normal man. Metabolism 1970;19:539–46.

Jankelson OM, Beaser SB, Howard RM, Maher J. Effect of coffee on glucose tolerance and circulating insulin in men with maturity-onset diabetes. Lancet 1967;1:527–9.

Naismith DJ, Akinayanju PA, Szanto S, Yudkin J. The effect in volunteers of coffee and decaffeinated coffee on blood glucose, insulin, plasma lipids and some factors involved in blood clotting. Nutr Metabol 1970;12:144–51.

van Dam RM, Pasman WJ, Verhoef P. Effects of coffee consumption on fasting blood glucose and insulin concentrations: randomized controlled trials in healthy volunteers. Diabetes Care 2004;27:2990–2.

Pencek RR, Battram D, Shearer J, et al. Portal vein caffeine infusion enhances net hepatic glucose uptake during a glucose load in conscious dogs. J Nutr 2004;134:3042–6.

Thong FS, Derave W, Kiens B, et al. Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise. Diabetes 2002;51:583–90.

Wynne K, Stanley S, Bloom S. The gut and regulation of body weight. J Clin Endocrinol Metab 2004;89:2576–82.

Avogaro A, Toffolo G, Valerio A, Cobelli C. Epinephrine exerts opposite effects on peripheral glucose disposal and glucose-stimulated insulin secretion. Diabetes 1996;45:1373–8.

Laaskso M, Edelman SV, Brechtel B, Baron AD. Effects of epinephrine on insulin-mediated glucose uptake in whole body and leg muscle in humans: role of blood flow. Am J Physiol Endocrinol Metab 1992;263:E199–204.

Van Soeren M, Mohr T, Kjaer M, Graham TE. Acute effects of caffeine ingestion at rest in humans with impaired epinephrine responses. J Appl Physiol 1996;80:999–1005.

Shi CL. The effects of caffeine and acetylcholine on glucose-stimulated insulin release from islet transplants in mice. Cell Transplant 1997;6:33–7.

Bruton JD, Lemmens R, Shi C, et al. Ryanodine receptors of pancreatic beta-cells mediate a distinct context-dependent signal for insulin secretion. FASEB J 2003;17:301–3. Epub 2002 Dec 3.

Westerterp-Plantenga MS, Lejeune MPGM, Kovacs EMR. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res 2005;13:1195–204.

Robertson D, Forlich JC, Carr RK, et al. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 1978;298:181–6.

Casiglia E, Bongiovi S, Paleari CD, et al. Haemodynamic effects of coffee and caffeine in normal volunteers: a placebo-controlled clinical study. J Intern Med 1991;229:501–4.

Christensen B, Mosdol A, Retterstol L, Landaas S, Thelle DS. Abstention from filtered coffee reduces the concentrations of plasma homocysteine and serum cholesterol—a randomized controlled trial. Am J Clin Nutr 2001;74:302–7.

Izzo JL, Ghosal A, Kwong T, et al. Age and prior caffeine use alter the cardiovascular and adrenomedullary responses to oral caffeine. Am J Cardiol 1983;52:769–73.

Onrot J, Goldberg MR, Biaggioni I, Hollister AS, Kincaid D, Robertson D. Hemodynamic and humoral effects of caffeine in autonomic failure: therapeutic implications for postprandial hypotension. N Engl J Med 1985;313:549–54.

Lenders JWM, Morrie HLC, Smits P, Thien T. The effects of caffeine on the postprandial fall of blood pressure in the elderly. Age Ageing 1988;17:236–40.

Lipsitz LA, Hansen RWMM, Connelly CM, Kelly-Gagnon MM, Parker AJ. Haemodynamic and neurohumoral effects of caffeine in elderly patients with symptomatic postprandial hypotension: a double-blind, randomized, placebo-controlled study. Clin Sci 1994;87:259–67.

Del Rio G, Menozzi R, Zizzo G, et al. Increased cardiovascular response to caffeine in perimenopausal women before and during estrogen therapy. Eur J Endocrinol 1996;135:598–603.
Heseltine D, El-Jabri M, Ahmed F, Knox J. The effect of caffeine on postprandial blood pressure in the frail elderly. Postgrad Med J 1991;67:543–7.

Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 2005;23:921–8.

James JE. Is habitual coffeine use a preventable cardiovascular risk factor? Lancet 1997;349:279–81.

Shi J, Benowitz NI, Denaro CP, Sheiner LB. Pharmacokinetic-pharmacodymanic modeling of caffeine: tolerance to pressor effects. Clin Pharmacol Ther 1993;53:6–14.

Garattini S. Overview. In: Garattini S, ed. Caffeine, coffee and health. New York, NY: Raven Press, Ltd, 1993:399–403.

Health Canada Food Program. Fact sheet—it's your health: caffeine. Ottawa, Canada: Health Canada, 2006.

Viani R. The composition of coffee. In: Garattini S, ed. Caffeine, coffee and health. New York, NY: Raven Press, Ltd, 1993:17–41.

Christian MS, Brent RL. Teratogen update: evaluation of the reproductive and developmental risks of caffeine. Teratology 2001;64:51–78.

Browne ML. Maternal exposure to caffeine and risk of congenital anomalies: a systematic review. Epidemiology 2006;17:324–31.

Nehlig A, Debry G. Potential teratogenic and neurodevelopmental consequences of coffee and caffeine exposure: a review on human and animal data. Neurotoxicol Teratol 1994;16:531–43.

Etherton GM, Kochar MS. Coffee. Facts and controversies. Arch Fam Med 1993;2:317–22.

Narod SA, De Sanjose S, Victora C. Coffee during pregnancy: a reproductive hazard? Am J Obstet Gynecol 1991;164:1109–14.

Smith BD, Tola K. Caffeine: effects on psychological functioning and Performance. In: Spiller GA, ed. Caffeine. Boca Raton, FL: CRC Press, 1998:278–9.

Massey LK. Caffeine and the elderly. Drugs Aging 1998;13:43–50.

Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for kidney stones in women. Ann Intern Med 1998;128:534–40.

Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr 2001;74:694–700.

Hasling C, Sondergaard K, Charles P, Mosekilde L. Calcium metabolism in postmenopausal osteoporotic women is determined by dietary calcium and coffee intake. J Nutr 1992;122:1119–26.

Harris SS, Dawson-Hughes B. Caffeine and bone loss in healthy postmenopausal women. Am J Clin Nutr 1994;60:573–8.

Chown S. Caffeine increases the insulin/glucose response to an OGTT in obese and lean males. Doctoral dissertation. University of Guelph, Guelph, Canada, 2001.

de Galan BE, Tack CJ, Lenders JW, et al. Theophylline improves hypoglycemia unawareness in type 1 diabetes. Diabetes 2002;51:790–6.

James JE. Caffeine and cardiovascular health. In: Understanding caffeine: a biobehavioral analysis. London, United Kingdom: Sage Publication, 1997:80–102.

James JE. Caffeine and cancer. In: Understanding caffeine: a behavioral analysis. London, United Kingdom: Sage Publications, 1997:103–15.

Schwartzschild MA, Ascherio A. Caffeine and Parkinson's disease. In: Nehlig A, ed. Coffee, tea, chocolate, and the brain. Boca Raton, FL: CRC Press, 2004:147–59.

Graham TE, Hibbert E, Sathasivam P. Metabolic and exercise endurance effects of coffee and caffeine ingestion. J Appl Physiol 1998;85:883–9.

Tse SYH. Cholinomimetic compound: distinct from caffeine contained in coffee. II: muscarinic actions. J Pharm Sci 1992;81:449–52.

Nieuwenhoven MA, Brummer RJM, Brouns F. Gastrointestinal function during exercise: comparison of water, sports drink and sports drink with caffeine. J Appl Physiol 2000;89:1079–85.

Rodriguez de Sotillo DV, Hadley M. Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J Nutr Biochem 2002;13:717–26.

Clifford MN. Chlorogenic acid and other cinnamates—nature, occurrence, dietary burden, absorption and metabolism. J Sci Food Agric 2000;80:1033–43.

Arion WJ, Canfield WK, Ramos FC, et al. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys 1997;339:315–22.

McCarty MF. A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk. Med Hypoth 2004;64:848–53.

Shearer J, Farah A, de Paulis R, et al. Quinides of roasted coffee enhance insulin action in conscious rats. J Nutr 2003;133:3529–32.

Natella R, Nardini M, Giannetti I, Dattile C, Scaccini C. Coffee drinking influences plasma antioxidant capacity in humans. J Agric Food Chem 2002;50:6211–6.

Svilaas A, Sakhi AK, Andersen LF, et al. Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 2004;134:562–7.

Copyright Fitness Coffee GVM 2017 - All rights reserved Top page